PROSE

Supports PROSE Treatment Growth Dr. Britney Kitamata-Wong, UCSF Needham, Mass. –June 21, 2022 – BostonSight® announced today that Britney Kitamata-Wong, OD, FAAO, FSLS, has joined the PROSE Provider Network at the University of California, San Francisco site. Dr. Kitamata-Wong joins Dr. James Li at UCSF as the need for PROSE treatment grows. They are part of a select group of PROSE-trained Fellows, with fewer than 30 optometrists in the world holding this designation. PROSE® is a medical treatment that saves sight in individuals with severe ocular surface disease.  For many people, PROSE is often their only option to restore visual function and end suffering from critical and devastating eye issues resulting from complications of severe dry eye, keratoconus, ocular GVHD, Sjögren’s Syndrome, Stevens Johnson Syndrome, corneal damage or injury, and other corneal diseases. PROSE treatment teams include cornea specialist ophthalmologists and optometrists who have completed an intensive BostonSight PROSE Clinical Fellowship. During treatment, doctors customize prosthetic lens devices from gas-permeable polymers for each patient’s condition and unique eye shape. PROSE teams work in partnership with the patients’ other medical providers to ensure that treatment manages the underlying eye condition. Dr. Kitamata-Wong earned her Doctor of Optometry degree at the University of California, Berkeley, School of Optometry. She completed a residency in cornea and contact lenses at the Southern California College of Optometry at Marshall B. Ketchum University. Her clinical interests include visual rehabilitation and contact lens management for patients with ocular surface disease and corneal irregularities. Dr. Kitamata-Wong has worked in clinical research relating to contact [...]

Expanded role will include developing BostonSight’s Educational Center of Excellence Dr. Karen G. Carrasquillo Needham, Mass. –June 7, 2022 – BostonSight®, a nonprofit eye healthcare organization and research center dedicated to saving sight and improving quality of life for patients, announced today that Karen G. Carrasquillo, OD, PhD, FAAO, FSLS, FBCLA, has been promoted to Senior Vice President, Clinical and Professional Affairs.  Dr. Carrasquillo previously served as Vice President, Clinical and Professional Affairs. In this expanded role, Dr. Carrasquillo will build upon BostonSight’s educational initiatives by developing BostonSight’s educational center of excellence, which will provide education on scleral lenses and the treatment of ocular surface diseases. She will have broad responsibility for the development and growth of global market knowledge and demand for BostonSight lenses, treatments, innovations, research, and technologies. “Dr. Carrasquillo’s passion and drive to educate, raise awareness, and promote our work has been a key driver in elevating BostonSight’s reputation to a well-recognized, supportive, and collaborative organization,” said Sara Yost, BostonSight President and CEO. “Her unwavering commitment to BostonSight’s mission and vision has created a bridge to the international scleral lens community.” Dr. Carrasquillo has a remarkable resume. She has contributed a vast amount of knowledge to the scleral lens industry based on her years of clinical and medical device design experience. In 2015, she led BostonSight in the research and development of the patented BostonSight SCLERAL FitKit®. She has been vital to the product’s success over the past 5 years and continues to lead product [...]

Increasing Access to Life-Changing Treatment that Saves Sight in People with Severe Corneal Disease BostonSight® announced today they welcomed The Ohio State University Wexner Medical Center as the newest PROSE® Provider Network site along with Drs. Chantelle Mundy, OD, and Stephanie Pisano, OD. With the addition of Ohio State Wexner Medical Center, the BostonSight PROSE Provider Network now includes 19 sites in four countries. PROSE by BostonSight is a medical treatment that saves sight in individuals with ocular surface disease. For many people, PROSE is often their only option to restore visual function and end suffering from critical and devastating eye issues resulting from complications of severe dry eye, keratoconus, ocular GVHD, Sjögren’s Syndrome, Stevens-Johnson Syndrome, corneal damage or injury, and other corneal diseases. PROSE treatment teams include cornea specialist ophthalmologists and optometrists who have completed an intensive BostonSight PROSE Clinical Fellowship. During treatment, doctors customize prosthetic lens devices from gas-permeable polymers for each patient’s condition and unique eye shape. PROSE teams work in partnership with the patients’ other medical providers to ensure that treatment manages the underlying eye condition. “At BostonSight we continue to expand our network of PROSE providers so that more patients can access this life-changing treatment,” said Sara Yost, BostonSight President and CEO. “With the addition of Ohio State Wexner Medical Center, we can help more patients in central Ohio and beyond. We are excited to welcome Dr. Mundy and Dr. Pisano, and the Wexner Medical Center team, to the PROSE Network.” Dr. Chantelle Mundy [...]